<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1</volume><submitter>Fleischmann C</submitter><pubmed_abstract>&lt;b>Objectives:&lt;/b> To examine the supplementation effects of the xanthophyll carotenoid Astaxanthin on physical performance and exertional heat strain in humans. &lt;b>Design:&lt;/b> A randomized double blind placebo controlled trial. &lt;b>Methods:&lt;/b> Twenty two male participants (Age: 23.14 ± 3.5 y, height: 175 ± 6 cm, body mass: 69.6 ± 8.7 kg, % body fat: 16.8 ± 3.8) received placebo (PLA, &lt;i>n&lt;/i> = 10) or Astaxanthin (ATX, &lt;i>n&lt;/i> = 12) 12 mg/day Per os (P.O), for 30 days, and were tested pre and post-supplementation with a maximal oxygen uptake (VO&lt;sub>2&lt;/sub> Max) test and the heat tolerance test (HTT) (2 h walk at 40°C, 40% relative humidity (RH), 5 kph, 2% incline). NIH database registration no. NCT02088242. Gas exchange, Heart rate (HR), Relative perceived exertion (RPE), and blood lactate were measured during the VO&lt;sub>2&lt;/sub> Max test. Heart rate (HR), rectal (Trec), and skin (Tskin) temperatures, RPE, and sweat rate (SR) were monitored in the HTT. Serum heat shock protein 72 (HSP72), Creatine phospho-kinase (CPK), C-reactive protein (CRP), and lipid profile were measured before and after the test. &lt;b>Results:&lt;/b> The rise in blood lactate caused by the VO&lt;sub>2&lt;/sub> Max test was significantly diminished in the ATX group (9.4 ± 3.1 and 13.0 ± 3.1 mmole&lt;sup>*&lt;/sup>l&lt;sup>-1&lt;/sup> in the ATX and PLA groups, respectively &lt;i>P&lt;/i> &lt; 0.02), as was the change in oxygen uptake during recovery (-2.02 ± 0.64 and 0.83 ± 0.79% of VO&lt;sub>2&lt;/sub> Max in the ATX and PLA group, respectively, &lt;i>p&lt;/i> = 0.001). No significant differences were observed in the anaerobic threshold or VO&lt;sub>2&lt;/sub> Max. In the HTT, no significant physiological or biochemical differences were observed (HR &lt;120 bpm, Trec rose by ~1°C to &lt;38°C, no difference in SR). &lt;b>Conclusions:&lt;/b> Astaxanthin supplementation improved exercise recovery. No benefit was observed for ATX over PLA in response to heat stress. Further examination of Astaxanthin in higher exertional heat strain is required.</pubmed_abstract><journal>Frontiers in sports and active living</journal><pagination>17</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7739736</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Asthaxanthin Improves Aerobic Exercise Recovery Without Affecting Heat Tolerance in Humans.</pubmed_title><pmcid>PMC7739736</pmcid><pubmed_authors>Fleischmann C</pubmed_authors><pubmed_authors>Raz H</pubmed_authors><pubmed_authors>Horowitz M</pubmed_authors><pubmed_authors>Heled Y</pubmed_authors><pubmed_authors>Yanovich R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Asthaxanthin Improves Aerobic Exercise Recovery Without Affecting Heat Tolerance in Humans.</name><description>&lt;b>Objectives:&lt;/b> To examine the supplementation effects of the xanthophyll carotenoid Astaxanthin on physical performance and exertional heat strain in humans. &lt;b>Design:&lt;/b> A randomized double blind placebo controlled trial. &lt;b>Methods:&lt;/b> Twenty two male participants (Age: 23.14 ± 3.5 y, height: 175 ± 6 cm, body mass: 69.6 ± 8.7 kg, % body fat: 16.8 ± 3.8) received placebo (PLA, &lt;i>n&lt;/i> = 10) or Astaxanthin (ATX, &lt;i>n&lt;/i> = 12) 12 mg/day Per os (P.O), for 30 days, and were tested pre and post-supplementation with a maximal oxygen uptake (VO&lt;sub>2&lt;/sub> Max) test and the heat tolerance test (HTT) (2 h walk at 40°C, 40% relative humidity (RH), 5 kph, 2% incline). NIH database registration no. NCT02088242. Gas exchange, Heart rate (HR), Relative perceived exertion (RPE), and blood lactate were measured during the VO&lt;sub>2&lt;/sub> Max test. Heart rate (HR), rectal (Trec), and skin (Tskin) temperatures, RPE, and sweat rate (SR) were monitored in the HTT. Serum heat shock protein 72 (HSP72), Creatine phospho-kinase (CPK), C-reactive protein (CRP), and lipid profile were measured before and after the test. &lt;b>Results:&lt;/b> The rise in blood lactate caused by the VO&lt;sub>2&lt;/sub> Max test was significantly diminished in the ATX group (9.4 ± 3.1 and 13.0 ± 3.1 mmole&lt;sup>*&lt;/sup>l&lt;sup>-1&lt;/sup> in the ATX and PLA groups, respectively &lt;i>P&lt;/i> &lt; 0.02), as was the change in oxygen uptake during recovery (-2.02 ± 0.64 and 0.83 ± 0.79% of VO&lt;sub>2&lt;/sub> Max in the ATX and PLA group, respectively, &lt;i>p&lt;/i> = 0.001). No significant differences were observed in the anaerobic threshold or VO&lt;sub>2&lt;/sub> Max. In the HTT, no significant physiological or biochemical differences were observed (HR &lt;120 bpm, Trec rose by ~1°C to &lt;38°C, no difference in SR). &lt;b>Conclusions:&lt;/b> Astaxanthin supplementation improved exercise recovery. No benefit was observed for ATX over PLA in response to heat stress. Further examination of Astaxanthin in higher exertional heat strain is required.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-04T10:12:02.037Z</modification><creation>2025-04-04T10:12:02.037Z</creation></dates><accession>S-EPMC7739736</accession><cross_references><pubmed>33344941</pubmed><doi>10.3389/fspor.2019.00017</doi></cross_references></HashMap>